Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Closed 06-18 16:00:00 EDT

893.39

-13.78

-1.52%

High907.74	Low885.65	Vol546.40M
Open907.17	D1 Closing907.17	Amplitude2.44%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O25.62B	T/O Rate--	Tradable Shares0.00
P/B5.365952	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":893.3894,"timestamp":1781812799999,"preClose":907.1722,"halted":0,"volume":546402720,"delay":0,"changeRate":-0.015193,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-13.782776,"latestTime":"06-18 16:00:00 EDT","open":907.1722,"high":907.742,"low":885.6519,"amount":25618929684.248707,"amplitude":0.02435,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1781827200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.365952,"peRate":27.132615,"turnoverRate":0.012311,"increases":95,"decrements":89,"flats":5,"marketCap":3470591840755.5,"floatMarketCap":3324597053517.0625},"requestUrl":"/m/hq/s/BK4007/wiki","defaultTab":"wiki","newsList":[{"id":"2644918034","title":"Argentina's Government Awards Tender for Key Grain Transport Waterway to Jan De Nul and Servimagnus","url":"https://stock-news.laohu8.com/highlight/detail?id=2644918034","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644918034?lang=en_us&edition=fundamental","pubTime":"2026-06-19 06:40","pubTimestamp":1781822403,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nS0N41D008:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4225","BK4120","JAN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644034625","title":"Cadrenal Therapeutics Chairman, CEO and Interim CFO Quang X. Pham disposes of $13,127 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2644034625","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644034625?lang=en_us&edition=fundamental","pubTime":"2026-06-19 06:37","pubTimestamp":1781822242,"startTime":"0","endTime":"0","summary":"Cadrenal Therapeutics chairman, CEO, interim CFO Quang X. Pham sold 4,126 common shares on June 16–17 at weighted-average prices of USD 3.18, USD 3.16.Directly held stake fell to 128,589 common shares following the sales.Separate indirect holding of 200,000 common shares was reported through The PVBQ Living Trust.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cadrenal Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL36NgNz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Cadrenal Therapeutics Chairman, CEO and Interim CFO Quang X. Pham disposes of $13,127 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644031798","title":"Akanda Corp. Flags Nasdaq Deficiency After Reporting Negative Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2644031798","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644031798?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:47","pubTimestamp":1781819231,"startTime":"0","endTime":"0","summary":"The latest update is out from Akanda Corp ( ($AKAN) ). On June 18, 2026, Akanda Corp. disclosed that it received a Nasdaq notification on June 16, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/akanda-corp-flags-nasdaq-deficiency-after-reporting-negative-equity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/akanda-corp-flags-nasdaq-deficiency-after-reporting-negative-equity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4215","EQR","BK4007","BK4585","NQmain","AKAN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644319770","title":"Teva Submits New Drug Application for Ecopipam to Treat Pediatric Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2644319770","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644319770?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:35","pubTimestamp":1781818538,"startTime":"0","endTime":"0","summary":"Teva  said late Thursday it submitted a new drug application to the US Food and Drug Administration for ecopipam investigational therapy to treat pediatric Tourette syndrome, a chronic neuro-developmental disorder.The NDA submission is supported by phase 3 data, which showed ecopipam sharply delayed time to relapse compared with placebo in pediatric Tourette patients who had attained a clinical response during the open-label treatment period, the company said.Ecopipam has secured Orphan Drug and Fast Track designations from the FDA for the treatment of Tourette syndrome in pediatric patients, according to a statement.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4596","BK4559","BK4566","BK4588","BK4584","BK4557","BK4585","LU1983299246.USD","BK4007","LU2324357040.USD","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644315440","title":"Crinetics director Stephanie Okey disposes of 6,900 shares worth $247,127.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2644315440","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644315440?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:24","pubTimestamp":1781817861,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals director Stephanie Okey reported open-market sales of 6,900 common shares on June 17, 2026.Shares sold at volume-weighted average prices of $35.62 and $36.22.Okey’s direct holding fell to 6,400 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Crinetics Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL8SjDwm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Crinetics director Stephanie Okey disposes of 6,900 shares worth $247,127.44","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644318220","title":"Jaguar Health extends Streeterville promissory note maturity to Oct. 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2644318220","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644318220?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:16","pubTimestamp":1781817401,"startTime":"0","endTime":"0","summary":"Jaguar Health amended two $12 million royalty-interest financings with Uptown Capital, Streeterville Capital; minimum monthly royalty payment set at USD 750,000 starting Oct. 1, 2026.Streeterville royalty-interest amendment pushed the start of monthly payments to Oct. 1, 2026 from July 1, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDLL3YS7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JAGX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644031846","title":"Petros Pharmaceuticals appoints Robert Weinstein chief accounting officer, principal financial officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2644031846","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644031846?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:15","pubTimestamp":1781817320,"startTime":"0","endTime":"0","summary":"Petros Pharmaceuticals separated from Vice President of Finance Mitchell Arnold, effective June 18, 2026.Robert Weinstein was appointed chief accounting officer, principal financial officer, principal accounting officer, effective immediately.Weinstein has over 30 years in accounting, investment banking, healthcare private equity, including CFO roles at TAO Synergies, Green Energy Management Services, Xcorporeal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Petros Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the inform","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL54z5KY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTPI","BK4007","XCRP","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644039071","title":"Curanex Pharmaceuticals files draft information statement (Form PRE 14C)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644039071","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644039071?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:12","pubTimestamp":1781817177,"startTime":"0","endTime":"0","summary":"Curanex shareholders authorized a reverse stock split of common stock, with the ratio set within a 1-for-10 to 1-for-50 range.The board would select the final split ratio, with the move aimed at lifting the per-share trading price.Shareholders also authorized a 2026 equity incentive plan reserving up to 5,700,000 common shares for awards to employees, directors, consultants.The plan includes an annual share reserve increase of up to 4% of outstanding shares, subject to administrator discretion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curanex Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL2yBSHS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CURX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644397420","title":"HRT Financial LP disposes of $73,191 in Clearmind Medicine common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2644397420","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644397420?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:06","pubTimestamp":1781816779,"startTime":"0","endTime":"0","summary":"HRT Financial LP cut its stake in Clearmind Medicine, selling 22,139 Class A shares on June 16.The shares were sold at USD 3.31 each.HRT Financial LP reported 81,353 Class A shares beneficially owned following the sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL1yFnJx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"HRT Financial LP disposes of $73,191 in Clearmind Medicine common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CMND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644903923","title":"Akanda Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders’ Equity Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2644903923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644903923?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:01","pubTimestamp":1781816497,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0UA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AKAN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644039268","title":"Akanda gets Nasdaq notice for failing to meet $2.5 million minimum stockholders’ equity rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2644039268","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644039268?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:01","pubTimestamp":1781816469,"startTime":"0","endTime":"0","summary":"Akanda received a Nasdaq notice for noncompliance with Listing Rule 5550 minimum $2.5 million stockholders’ equity requirement.Stockholders’ equity was $-11.99 million in its annual report for the year ended Dec. 31, 2025.Nasdaq also found it failed alternative continued listing tests tied to market value of listed securities or net income from continuing operations.Shares remain listed for now; a compliance plan is due within 45 days of June 16, 2026, with a possible 180-day extension if accepted.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akanda Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL8vVC7b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AKAN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644392100","title":"Teva submits NDA for Ecopipam to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2644392100","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644392100?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:00","pubTimestamp":1781816411,"startTime":"0","endTime":"0","summary":"The company states: “Teva (TEVA) Pharmaceutical announced the submission of a New Drug Application to the U.S. Food and Drug Administration for eco...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-submits-nda-for-ecopipam-to-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-submits-nda-for-ecopipam-to-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4559","BK4566","LABU","LU2324357040.USD","BK4588","LU1983299246.USD","BK4596","BK4557","BK4585","BK4007","BK4584","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644391020","title":"Teva Releases Q2 2026 Aide Memoire","url":"https://stock-news.laohu8.com/highlight/detail?id=2644391020","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644391020?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:00","pubTimestamp":1781816400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nTUA68P4FZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4559","BK4588","BK4585","BK4584","TEVA","LU2324357040.USD","BK4007","LU1983299246.USD","BK4596","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644903910","title":"Teva - Ecopipam Showed Statistically Significant Benefit on Primary Efficacy Endpoint in Pediatric Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2644903910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644903910?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:57","pubTimestamp":1781816225,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0U9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TEVA","LU2324357040.USD","BK4007","BK4559","BK4596","BK4566","BK4584","BK4557","BK4585","LU1983299246.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644039170","title":"Zoetis Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2644039170","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644039170?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:57","pubTimestamp":1781816220,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Zoetis Inc.  rallied 1.88% to $78.71 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.08% to 7,500.58 and the Dow Jones Industrial Average  rising 0.14% to 51,564.70.The stock's rise snapped a two-day losing streak.Zoetis Inc. closed 51.34% below its 52-week high of $161.77, which the company reached on July 10th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Merck & Co. Inc.  fell 1.36% to $113.87 and IDEXX Laboratories Inc.  rose 2.93% to $562.09.Trading volume  eclipsed its 50-day average volume of 6.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721429402.USD","IE00B19Z9505.USD","LU0058720904.USD","BK4585","ZTS","LU2023251221.USD","LU0345774631.USD","LU0385154629.USD","BK4534","LU0471298777.SGD","LU2089283258.USD","LU2271345857.HKD","LU0158827781.USD","BK4588","LU2111349929.HKD","LU0345774391.USD","LU2360106947.USD","LU0471298694.HKD","LU2308191902.HKD","LU1721429741.USD","GB00BDT5M118.USD","LU2089284900.SGD","LU0289739699.SGD","BK4007","LU0079474960.USD","LU1236620834.HKD","LU1941712264.USD","LU1059921491.USD","LU2028103732.USD","LU0158827948.USD","LU1236620750.USD","LU1941712348.USD","LU0107464264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644039129","title":"Supernus Pharmaceuticals holds annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2644039129","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644039129?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:56","pubTimestamp":1781816176,"startTime":"0","endTime":"0","summary":"Supernus Pharmaceuticals held its annual shareholder meeting on June 18, 2026.Shareholders backed two director nominees to serve through the 2029 annual meeting.Shareholders adopted an amendment to the 2021 Equity Incentive Plan to increase the number of shares available under the plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Supernus Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL4hbcBg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SUPN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644039531","title":"Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2644039531","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644039531?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:39","pubTimestamp":1781815140,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  slid 2.32% to $54.00 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.08% to 7,500.58 and the Dow Jones Industrial Average  rising 0.14% to 51,564.70.This was the stock's fourth consecutive day of losses.Bristol Myers Squibb Co. closed 14.13% short of its 52-week high of $62.89, which the company reached on March 2nd.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.48% to $228.39, Pfizer Inc.  fell 2.74% to $25.21, and Abbott Laboratories  fell 0.10% to $88.41.Trading volume  eclipsed its 50-day average volume of 10.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670710588.SGD","LU0868494617.USD","LU2242652126.USD","LU1868836914.USD","LU1983299246.USD","LU1868836757.USD","IE0009355771.USD","LU0061475181.USD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU0321505439.SGD","BK4581","LU1989771016.USD","LU2133065610.SGD","LU2360032135.SGD","LU1571399168.USD","LU1093756168.USD","LU1670710661.SGD","LU1585245621.USD","BK4532","LU1868837300.USD","LU2125154935.USD","LU1074936037.SGD","LU1430594728.SGD","LU0321505868.SGD","LU1670711123.USD","LU1093756325.SGD","LU1868837136.USD","BMY","LU0267386448.USD","IE0002141913.USD","LU1261432733.SGD","IE00B2B36J28.USD","LU0306807586.USD","BK4534","IE00BJT1NW94.SGD","LU2596442595.SGD","IE00BFTCPJ56.SGD","LU1718418525.SGD","LU0432979614.USD","LU1670711040.USD","BK4585","LU0096364046.USD","BK4559","LU1291159041.SGD","IE00BSNM7G36.USD","LU1868836591.USD","LU2125154778.USD","BK4588","LU1032466523.USD","LU1883839398.USD","IE00BFXG1179.USD","LU0882574055.USD","LU0225284248.USD","LU0306806265.USD","LU0985481810.HKD","LU0456855351.SGD","LU0225771236.USD","LU0237698245.USD","LU2242646821.SGD","LU0114720955.EUR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644377039","title":"Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2644377039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644377039?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:36","pubTimestamp":1781814960,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Pfizer Inc.  slipped 2.74% to $25.21 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.08% to 7,500.58 and the Dow Jones Industrial Average  rising 0.14% to 51,564.70.This was the stock's second consecutive day of losses.Pfizer Inc. closed 12.30% short of its 52-week high of $28.75, which the company reached on April 2nd.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.48% to $228.39, Eli Lilly & Co.  fell 1.21% to $1,098.57, and Abbott Laboratories  fell 0.10% to $88.41.Trading volume  eclipsed its 50-day average volume of 34.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IE00BLSP4239.USD","LU0289739699.SGD","IE00BLSP4452.SGD","LU1066051498.USD","LU0225284248.USD","LU1023059063.AUD","BK4550","LU1894683348.USD","IE00B3T34201.USD","SG9999013999.USD","BK4568","BK4533","BK4599","LU0306807586.USD","LU2596442595.SGD","SGXZ57979304.SGD","BK4588","LU0225771236.USD","SG9999003800.SGD","LU0456855351.SGD","PFE","LU0868494617.USD","BK4534","SG9999002224.SGD","LU0234572021.USD","LU1883839398.USD","BK4581","LU0306806265.USD","LU0321505439.SGD","LU1066053197.SGD","IE00B19Z3B42.SGD","LU0122379950.USD","SG9999001176.USD","LU1894683264.USD","BK4007","BK4585","IE00BBT3K403.USD","SG9999011175.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE000M9KFDE8.USD","LU0321505868.SGD","LU1057294990.SGD","LU0170899867.USD","BK4592","SG9999001176.SGD","LU0985481810.HKD","SG9999002232.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644398640","title":"Prf Technologies: Enters Purchase Agreement With Yorkville; May Sell Shares of up to $15 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2644398640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644398640?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:34","pubTimestamp":1781814893,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q12Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644703989","title":"Sonoma Pharma ups at-the-market stock offering to $3.64 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2644703989","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644703989?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:34","pubTimestamp":1781814869,"startTime":"0","endTime":"0","summary":"Sonoma Pharmaceuticals increased the size of its at-the-market equity program to USD 3.64 million under its sales agreement with Ladenburg Thalmann.Supplement filed to raise the aggregate offering amount to USD 3.64 million, including 1,495,830 registered shares not yet sold.Sold 173,073 shares for USD 574,633 under the program from Sept. 26, 2025 through June 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonoma Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL7bCQQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNOA","BK4127","BK4557","BK4007","LTSAP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0214},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.123},{"period":"6month","weight":0.0887},{"period":"1year","weight":0.24},{"period":"ytd","weight":0.0866}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}